FindTrial
Sign In

Lipoprotein (a) and apolipoprotein B have been reported to be a better predictor of coronary artery disease than cholesterol indices among type 2 diabetes mellitus and healthy individuals

Comparative analysis of extended lipid profile in type 2 Diabetes Mellitus and normoglycemic patients with and without CAD: a cross sectional study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094727
Enrollment
1200
Registered
2025-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications Health Condition 2: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

Intervention1: Nil: Nil

Sponsors

Ankana Debnath
Lead Sponsor
CHARU YADAV
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 Diabetes mellitus and normoglycemics as per the ADA Diagnostic criteria shall be included The above subjects shall be further grouped into with and without CAD based on history, ECG, stress Echo and Angiography findings.

Exclusion criteria

Exclusion criteria: Known cases of chronic kidney diseases and nephrotic syndrome Acute illness, recent hospitalization. Chronic liver diseases, autoimmuno disorder, inflammatory condition. Known cases of familial dyslipidemia on treatment other than statin such as PCSK9 inhibitors, fibrates, ezetimibe drugs. Pregnant women and lactation Active malignancy Severe hypothyroidism Acute diabetes complications (DKA, HHS) Other specific type of diabetes ( type 1 DM, MODY, LADA) Smokers and chronic alcoholics

Design outcomes

Primary

MeasureTime frame
Comparison of extended lipid profile [Lp(a), apoB, Total cholesterol,Triglycerides, LDL, HDL] in type 2 diabetes and normoglycemics with and without CAD. Timepoint: 1 year sept 2025 to sept 2026—

Secondary

MeasureTime frame
To correlate Lp(a) & Apo B with glycemic indices & insulin resistance. Timepoint: 1 year , sept 2025 to sept 2026—

Countries

India

Contacts

Public ContactAnkana Debnath

MEDANTA THE MEDICITY

Charu.Yadav@medanta.org9739766824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026